Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc. (MDGL) — Form 8-K: Current report
About this filing
Madrigal Pharmaceuticals Inc. (MDGL) filed an 8-K on Nov 3, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More MDGL filings
- SC 13D/A
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 6, 2026
- 10-Q
Filed Nov 3, 2026
- 144
Filed Sep 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.